PET/CT in the management of thyroid cancers

Charles Marcus, Pat W. Whitworth, Devaki S. Surasi, Sara I. Pai, Rathan M. Subramaniam

Research output: Contribution to journalArticle

Abstract

OBJECTIVE. Thyroid cancer is the most common endocrine cancer. This review evaluates the established use of 18F-FDG PET/CT in papillary, follicular, Hürthle cell, anaplastic, and medullary thyroid cancers. The significance of incidental diffuse and focal thyroid FDG uptake is discussed. The evolving value of non-FDG radiotracers, including 124I, 18F-dihydroxyphenylalanine, and 68Ga somatostatin analogs, is summarized. CONCLUSION. PET/CT is a valuable imaging test, in the appropriate clinical context, for the management of thyroid cancers.

Original languageEnglish (US)
Pages (from-to)1316-1329
Number of pages14
JournalAmerican Journal of Roentgenology
Volume202
Issue number6
DOIs
StatePublished - 2014

Fingerprint

Thyroid Neoplasms
Endocrine Gland Neoplasms
Dihydroxyphenylalanine
Fluorodeoxyglucose F18
Somatostatin
Thyroid Gland
Medullary Thyroid cancer
Anaplastic Thyroid Carcinoma

Keywords

  • F-DOPA PET/CT
  • FDG PET/CT
  • Thyroid cancer

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Marcus, C., Whitworth, P. W., Surasi, D. S., Pai, S. I., & Subramaniam, R. M. (2014). PET/CT in the management of thyroid cancers. American Journal of Roentgenology, 202(6), 1316-1329. https://doi.org/10.2214/AJR.13.11673

PET/CT in the management of thyroid cancers. / Marcus, Charles; Whitworth, Pat W.; Surasi, Devaki S.; Pai, Sara I.; Subramaniam, Rathan M.

In: American Journal of Roentgenology, Vol. 202, No. 6, 2014, p. 1316-1329.

Research output: Contribution to journalArticle

Marcus, C, Whitworth, PW, Surasi, DS, Pai, SI & Subramaniam, RM 2014, 'PET/CT in the management of thyroid cancers', American Journal of Roentgenology, vol. 202, no. 6, pp. 1316-1329. https://doi.org/10.2214/AJR.13.11673
Marcus C, Whitworth PW, Surasi DS, Pai SI, Subramaniam RM. PET/CT in the management of thyroid cancers. American Journal of Roentgenology. 2014;202(6):1316-1329. https://doi.org/10.2214/AJR.13.11673
Marcus, Charles ; Whitworth, Pat W. ; Surasi, Devaki S. ; Pai, Sara I. ; Subramaniam, Rathan M. / PET/CT in the management of thyroid cancers. In: American Journal of Roentgenology. 2014 ; Vol. 202, No. 6. pp. 1316-1329.
@article{27a4c9be654947d781cad0705f4dc7e6,
title = "PET/CT in the management of thyroid cancers",
abstract = "OBJECTIVE. Thyroid cancer is the most common endocrine cancer. This review evaluates the established use of 18F-FDG PET/CT in papillary, follicular, H{\"u}rthle cell, anaplastic, and medullary thyroid cancers. The significance of incidental diffuse and focal thyroid FDG uptake is discussed. The evolving value of non-FDG radiotracers, including 124I, 18F-dihydroxyphenylalanine, and 68Ga somatostatin analogs, is summarized. CONCLUSION. PET/CT is a valuable imaging test, in the appropriate clinical context, for the management of thyroid cancers.",
keywords = "F-DOPA PET/CT, FDG PET/CT, Thyroid cancer",
author = "Charles Marcus and Whitworth, {Pat W.} and Surasi, {Devaki S.} and Pai, {Sara I.} and Subramaniam, {Rathan M.}",
year = "2014",
doi = "10.2214/AJR.13.11673",
language = "English (US)",
volume = "202",
pages = "1316--1329",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "6",

}

TY - JOUR

T1 - PET/CT in the management of thyroid cancers

AU - Marcus, Charles

AU - Whitworth, Pat W.

AU - Surasi, Devaki S.

AU - Pai, Sara I.

AU - Subramaniam, Rathan M.

PY - 2014

Y1 - 2014

N2 - OBJECTIVE. Thyroid cancer is the most common endocrine cancer. This review evaluates the established use of 18F-FDG PET/CT in papillary, follicular, Hürthle cell, anaplastic, and medullary thyroid cancers. The significance of incidental diffuse and focal thyroid FDG uptake is discussed. The evolving value of non-FDG radiotracers, including 124I, 18F-dihydroxyphenylalanine, and 68Ga somatostatin analogs, is summarized. CONCLUSION. PET/CT is a valuable imaging test, in the appropriate clinical context, for the management of thyroid cancers.

AB - OBJECTIVE. Thyroid cancer is the most common endocrine cancer. This review evaluates the established use of 18F-FDG PET/CT in papillary, follicular, Hürthle cell, anaplastic, and medullary thyroid cancers. The significance of incidental diffuse and focal thyroid FDG uptake is discussed. The evolving value of non-FDG radiotracers, including 124I, 18F-dihydroxyphenylalanine, and 68Ga somatostatin analogs, is summarized. CONCLUSION. PET/CT is a valuable imaging test, in the appropriate clinical context, for the management of thyroid cancers.

KW - F-DOPA PET/CT

KW - FDG PET/CT

KW - Thyroid cancer

UR - http://www.scopus.com/inward/record.url?scp=84904107810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904107810&partnerID=8YFLogxK

U2 - 10.2214/AJR.13.11673

DO - 10.2214/AJR.13.11673

M3 - Article

C2 - 24848831

AN - SCOPUS:84904107810

VL - 202

SP - 1316

EP - 1329

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 6

ER -